FDA Says Abilify Promo Is Misleading
The U.S. Food and Drug Administration has blasted one of Otsuka Pharmaceutical Co. Ltd.'s Abilify advertisements, saying it makes misleading claims about the antipsychotic drug that aren't supported by any known...To view the full article, register now.
Already a subscriber? Click here to view full article